ANTICOAGULANT SODIUM CITRATE TRISODIUM CITRATE DIHYDRATE BAXTER HEALTHCARE CORPORATION FDA Approved INDICATIONS AND USAGE Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.
FunFoxMeds bottle
Route
EXTRACORPOREAL
Applications
BN980123
Package NDC

Drug Facts

Composition & Profile

Strengths
4 %
Quantities
250 ml 100 ml
Treats Conditions
Indications And Usage Anticoagulant Sodium Citrate 4 W V Solution Usp Is Intended For Use Only With Automated Apheresis Devices

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UNII
B22547B95K
Packaging

HOW SUPPLIED Anticoagulant Sodium Citrate 4% w/v Solution, USP is a clear solution supplied in sterile and nonpyrogenic PVC bags per carton. Storage and Handling Store at room temperature (25C/77F). Avoid excessive heat. Protect from freezing.; PACKAGE/LABEL PRINCIPAL DISPLAY PANEL LOT EXP 2B7867 NDC 0338-9669-01 Anticoagulant Sodium Citrate 4% w/v Solution USP Rx only 250 mL EACH 100 mL CONTAINS 4 g SODIUM CITRATE (DIHYDRATE) USP pH ADJUSTED WITH CITRIC ACID STERILE NONPYROGENIC INTENDED FOR USE ONLY WITH AUTOMATED APHERESIS DEVICES CAUTION — NOT FOR DIRECT INTRAVENOUS INFUSION THE POUCH IS A MOISTURE BARRIER DO NOT USE UNLESS SOLUTION IS CLEAR SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND SINGLE USE CONTAINER DISCARD UNUSED PORTION DIRECTIONS FOR USE ARE CONTAINED IN THE OWNERS OPERATING AND MAINTENANCE MANUAL OF THE APHERESIS MACHINE TO BE USED RECOMMENDED STORAGE ROOM TEMPERATURE (25C/77F) AVOID EXCESSIVE HEAT PROTECT FROM FREEZING. FOR PRODUCT INFORMATION 1-800-933-0303 BAXTER IS A TRADEMARK OF BAXTER INTERNATIONAL Baxter Logo BAXTER HEALTHCARE CORPORATION DEERFIELD IL 60015 USA MADE IN USA 07-25-00-4675 Carton Label

Package Descriptions
  • HOW SUPPLIED Anticoagulant Sodium Citrate 4% w/v Solution, USP is a clear solution supplied in sterile and nonpyrogenic PVC bags per carton. Storage and Handling Store at room temperature (25C/77F). Avoid excessive heat. Protect from freezing.
  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL LOT EXP 2B7867 NDC 0338-9669-01 Anticoagulant Sodium Citrate 4% w/v Solution USP Rx only 250 mL EACH 100 mL CONTAINS 4 g SODIUM CITRATE (DIHYDRATE) USP pH ADJUSTED WITH CITRIC ACID STERILE NONPYROGENIC INTENDED FOR USE ONLY WITH AUTOMATED APHERESIS DEVICES CAUTION — NOT FOR DIRECT INTRAVENOUS INFUSION THE POUCH IS A MOISTURE BARRIER DO NOT USE UNLESS SOLUTION IS CLEAR SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND SINGLE USE CONTAINER DISCARD UNUSED PORTION DIRECTIONS FOR USE ARE CONTAINED IN THE OWNERS OPERATING AND MAINTENANCE MANUAL OF THE APHERESIS MACHINE TO BE USED RECOMMENDED STORAGE ROOM TEMPERATURE (25C/77F) AVOID EXCESSIVE HEAT PROTECT FROM FREEZING. FOR PRODUCT INFORMATION 1-800-933-0303 BAXTER IS A TRADEMARK OF BAXTER INTERNATIONAL Baxter Logo BAXTER HEALTHCARE CORPORATION DEERFIELD IL 60015 USA MADE IN USA 07-25-00-4675 Carton Label

Overview

INDICATIONS AND USAGE Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.

Indications & Usage

Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.

Dosage & Administration

Not available

Warnings & Precautions
No warnings available yet.
Storage & Handling

Storage and Handling Store at room temperature (25C/77F). Avoid excessive heat. Protect from freezing.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →